Abbott Laboratories (ABT) Liabilities from Discontinued Operations (2009 - 2016)

Abbott Laboratories has reported Liabilities from Discontinued Operations for 5 years, with the latest figure at 245000000.0 in Q4 2016.

• Quarterly Liabilities from Discontinued Operations fell 34.32% year-over-year to 245000000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was 245000000.0 (down 34.32% YoY) and the FY2016 annual result came in at 245000000.0, down 34.32% from the prior year.
• Liabilities from Discontinued Operations retreated to 245000000.0 in Q4 2016 per ABT's latest filing, from 597000000.0 in the prior quarter.
• Over five years, Liabilities from Discontinued Operations peaked at 721000000.0 in Q3 2014 and troughed at 169000000.0 in Q1 2014.
• A 4-year average of 375214000.0 and a median of 352250000.0 in 2013 frame the typical range for Liabilities from Discontinued Operations.
• The sharpest annual moves came in 2014 and 2015: Liabilities from Discontinued Operations soared 106.89% in 2014, then tumbled 50.62% in 2015.
• Over 4 years, Liabilities from Discontinued Operations stood at 386000000.0 in 2013, then soared by 76.17% to 680000000.0 in 2014, then plunged by 45.15% to 373000000.0 in 2015, then sank by 34.32% to 245000000.0 in 2016.
• According to Business Quant data, Liabilities from Discontinued Operations over the past three periods registered 245000000.0, 597000000.0, and 361000000.0 for Q4 2016, Q3 2016, and Q2 2016 respectively.